Tocilizumab as a Potential Adjunctive Therapy to Corticosteroids in Cryptococcal Post-infectious Inflammatory Response Syndrome (PIIRS): a Report of Two Cases.
Jessica C HargartenSeher H AnjumKenneth SsebambuliddeYoon-Dong ParkMalcolm J VaughanTerri L ScottDima A HammoudBridgette Jeanne BilliouxPeter R WilliamsonPublished in: Journal of clinical immunology (2023)
Tocilizumab may be a safe adjunctive treatment for CM-related PIIRS suggesting further study.